Search by Drug Name or NDC

    NDC 00469-0420-99 CRESEMBA 40 mg/mL Details

    CRESEMBA 40 mg/mL

    CRESEMBA is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Astellas Pharma US, Inc.. The primary component is ISAVUCONAZONIUM SULFATE.

    Product Information

    NDC 00469-0420
    Product ID 0469-0420_a91d60a8-2fa7-4f5c-b10b-852309428863
    Associated GPIs 11407030102130
    GCN Sequence Number 073653
    GCN Sequence Number Description isavuconazonium sulfate VIAL 372 MG INTRAVEN
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 38094
    HICL Sequence Number 041817
    HICL Sequence Number Description ISAVUCONAZONIUM SULFATE
    Brand/Generic Brand
    Proprietary Name CRESEMBA
    Proprietary Name Suffix n/a
    Non-Proprietary Name isavuconazonium sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 40
    Active Ingredient Units mg/mL
    Substance Name ISAVUCONAZONIUM SULFATE
    Labeler Name Astellas Pharma US, Inc.
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA207501
    Listing Certified Through 2024-12-31

    Package

    NDC 00469-0420-99 (00469042099)

    NDC Package Code 0469-0420-99
    Billing NDC 00469042099
    Package 10 CARTON in 1 CARTON (0469-0420-99) / 1 VIAL, SINGLE-DOSE in 1 CARTON (0469-0420-01) / 5 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2015-03-06
    NDC Exclude Flag N
    Pricing Information N/A